FDA vs EMA Incentives: A Comparative Review
FDA vs EMA Incentives: A Comparative Review Comparing FDA and EMA Incentives for Rare Disease Drug Approvals Introduction: Why Incentives Matter in Rare Disease Drug Development Developing treatments for rare and ultra-rare diseases is often economically unviable without regulatory incentives. Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have…